Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United States remained the priciest Nitroxoline market tracked, rising just above 3.5% in Q2 2026 to near USD 385.00/KG from about USD 372.00/KG in Q1, and it was strong pharmaceutical-sector demand together with logistical bottlenecks affecting raw material shipments that kept the market elevated. The global average climbed from close to USD 238.50/KG to near USD 246.50/KG, a gain of roughly 3.4%. As the data shows, growing urinary tract infection prevalence tied to lifestyle changes and increasing antibiotic resistance has kept demand for this antibiotic firm across every market tracked, and the global average is likely to run in the USD 238 to 268/KG range through the second half of the year.
Nitroxoline is a hydroxyquinoline-derivative urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections, and it also disrupts biofilms associated with resistant infections. It treats conditions including urinary tract infections and prostatitis, and possesses antiangiogenic and anticancer properties through the inhibition of a specific enzyme. Demand is majorly driven by rising global prevalence of urinary tract infections tied to lifestyle changes and increasing traditional antibiotic resistance, with a growing aging population particularly susceptible to these conditions. Because this API depends on specific raw material inputs sourced internationally, global production challenges and logistical bottlenecks, regulatory adjustments affecting essential medicine pricing, and demand growth tied to antibiotic resistance and population aging are what really move the price from quarter to quarter.
Rising global prevalence of urinary tract infections, tied to lifestyle changes, increasing antibiotic resistance, and an aging population more susceptible to these conditions, shows no clear sign of slowing, which points toward continued gradual firmness through H2 2026 across every market tracked. Logistical bottlenecks affecting raw material shipments should remain a key variable regardless of region.
A further logistical disruption affecting overseas raw material shipments, or accelerating demand tied to antibiotic resistance, could be what pushes prices above this forecast. A resolution of supply chain bottlenecks, or a stabilization in production workforce availability, could be what eases the market back toward the lower end instead.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 238 - 268 | Steady demand and logistical bottlenecks support gains |
| United States | 375 - 400 | Strong pharmaceutical demand keeps market elevated |
| Germany | 215 - 235 | Manufacturing bottlenecks sustain firm pricing |
| France | 192 - 210 | Regulatory adjustments support gradual gains |
| United Kingdom | 180 - 198 | Labor shortages in the pharmaceutical supply chain |
The United States stayed the priciest market by a wide margin, with the price moving from about USD 372.00/KG to near USD 385.00/KG, a gain of just above 3.5%. It was continued strong demand from the pharmaceutical sector, together with ongoing logistical bottlenecks affecting raw material shipments, that carried the increase.
Why did the price of Nitroxoline change in Q2 2026 in United States?
Healthcare sector trends have continued shaping demand for this urinary antibacterial agent, and it is this steady pharmaceutical-sector pull, combined with delays in raw material shipments from overseas suppliers that keep disrupting production timelines, that has kept United States pricing on a steady upward path.
The German price moved from about USD 213.00/KG to near USD 220.00/KG, a gain of just above 3.3%. It was consistent pharmaceutical manufacturing activity, together with import and production bottlenecks in key manufacturing hubs, that carried the increase.
Why did the price of Nitroxoline change in Q2 2026 in Germany?
Import and production bottlenecks, particularly in key manufacturing hubs, have continued creating challenges in ensuring steady availability of raw materials, and it is this supply friction, combined with consistent pharmaceutical manufacturing activity and demand for specialized active pharmaceutical ingredients, that has kept German pricing on a gradual upward path.
The French price moved from about USD 190.00/KG to near USD 196.00/KG, a gain of just above 3.2%. It was regulatory and market dynamics, together with steady pharmaceutical demand, that carried the increase.
Why did the price of Nitroxoline change in Q2 2026 in France?
European regulatory bodies have continued monitoring the pharmaceutical landscape, leading to adjustments in pricing policies particularly for essential medicines like this one, and it is this regulatory attention, combined with steady demand from pharmaceutical formulators, that has kept French pricing on a gradual upward path.
The United Kingdom price moved from about USD 179.00/KG to near USD 185.00/KG, a gain of just above 3.4%. It was continued labor shortages within the pharmaceutical supply chain, together with steady demand, that carried the increase.
Why did the price of Nitroxoline change in Q2 2026 in United Kingdom?
Many manufacturers have continued facing challenges due to labor shortages and issues within the broader pharmaceutical supply chain, and it is this reduced workforce availability, combined with steady demand from pharmaceutical formulators, that has kept United Kingdom pricing on a gradual upward path.
The price reached close to USD 372.00/KG in Q1 2026, a rise of just above 4.8% from Q4 2025. It was global production challenges affecting critical inputs, together with ongoing logistical bottlenecks, that pushed the market higher.
Why did the price of Nitroxoline change in Q1 2026 in United States?
Several critical inputs for manufacturing this API experienced price volatility due to global production challenges, exacerbated by ongoing logistical bottlenecks, and it was delays in raw material shipments, especially from overseas suppliers, disrupting production timelines and creating a ripple effect in pricing, that drove the United States increase.
The price reached close to USD 213.00/KG in Q1 2026, a rise of just above 4.9% from Q4 2025. It was supply chain disruptions, together with steady pharmaceutical manufacturing demand, that pushed the market higher.
Why did the price of Nitroxoline change in Q1 2026 in Germany?
Supply chain disruptions played a major role in shaping pricing this quarter, with import and production bottlenecks in key manufacturing hubs creating challenges in ensuring steady raw material availability, and it was this constraint, meeting stable industrial operations and regulatory compliance requirements, that drove the German increase.
The price reached close to USD 190.00/KG in Q1 2026, a rise of just above 5.0% from Q4 2025. It was regulatory adjustments, together with steady demand, that pushed the market higher.
Why did the price of Nitroxoline change in Q1 2026 in France?
European regulatory bodies continued monitoring the pharmaceutical landscape this quarter, which led to some adjustments in pricing policies, and while not immediately drastic, these policy shifts set the stage for gradual price corrections that, combined with steady demand, drove the French increase.
The price reached close to USD 179.00/KG in Q1 2026, a rise of just above 4.7% from Q4 2025. It was efforts to stabilize production facing labor shortage challenges, that pushed the market higher.
Why did the price of Nitroxoline change in Q1 2026 in United Kingdom?
While there were some efforts to stabilize production in the United Kingdom, many manufacturers faced challenges due to labor shortages and issues within the broader pharmaceutical supply chain, and it was this reduced workforce availability, meeting steady demand, that drove the increase.
This market climbed steadily across every quarter tracked here. Close to USD 201.50/KG in Q1 2025 rose to about USD 209.75/KG, near USD 218.00/KG, and close to USD 227.50/KG by Q4, before continuing to about USD 238.50/KG in Q1 2026 and near USD 246.50/KG in Q2. That is a rise of roughly 22.3% across the window, tracking pharmaceutical-sector demand and logistical bottlenecks closely.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 246.50 | +3.4% | ↑ Rising |
| Q1 2026 | 238.50 | +4.8% | ↑ Rising |
| Q4 2025 | 227.50 | +4.4% | ↑ Rising |
| Q3 2025 | 218.00 | +3.9% | ↑ Rising |
| Q2 2025 | 209.75 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
It was rising global prevalence of urinary tract infections, meeting global production challenges and logistical bottlenecks affecting raw material shipments, that drove the consistent 2025 climb. The global average opened near USD 201.50/KG in Q1 and climbed to close to USD 227.50/KG by Q4, a rise of just above 12.9% for the year, with every quarter posting a gain.
The United States price climbed from about USD 315.00/KG in Q1 2025 to near USD 355.00/KG by Q4, a rise of just above 12.7% for the year, holding the highest absolute cost among the four markets tracked throughout. It was strong demand from the pharmaceutical sector, meeting global production challenges and logistical bottlenecks affecting raw material shipments, that drove the sustained climb through 2025.
The German price climbed from about USD 180.00/KG in Q1 2025 to near USD 203.00/KG by Q4, a rise of just above 12.8% for the year. It was consistent pharmaceutical manufacturing activity and demand for specialized active pharmaceutical ingredients, meeting supply chain disruptions tied to import and production bottlenecks, that drove the sustained climb through 2025.
The French price climbed from about USD 160.00/KG in Q1 2025 to near USD 181.00/KG by Q4, a rise of just above 13.1% for the year. It was regulatory and market dynamics affecting pricing policies for essential medicines, meeting steady pharmaceutical-sector demand, that drove the sustained climb through 2025.
The United Kingdom price climbed from about USD 151.00/KG in Q1 2025 to near USD 171.00/KG by Q4, a rise of just above 13.2% for the year, the largest annual gain among the four markets tracked. It was labor shortages and broader pharmaceutical supply chain issues, meeting steady demand from formulators, that drove the sustained climb through 2025.
Expert Market Research: Your Source for Real-Time Nitroxoline Price Intelligence
The Nitroxoline market depends heavily on international raw material supply chains and pharmaceutical-sector demand growth, so Expert Market Research tracks logistical bottlenecks affecting raw material shipments closely alongside regulatory developments and demand growth tied to urinary tract infection prevalence and antibiotic resistance across the four markets covered here. This is combined with trade flow data to build the forecasts. Should the Nitroxoline pricing data or procurement strategy support be needed, the team is ready to help.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It serves as the active pharmaceutical ingredient in urinary antibacterial medications treating urinary tract infections and prostatitis, and disrupts biofilms associated with resistant bacterial strains.
As of Q2 2026, the United States averages near USD 385.00/KG, Germany about USD 220.00/KG, France close to USD 196.00/KG, and the United Kingdom roughly USD 185.00/KG. The United States remains the priciest of the four markets tracked.
The price kept climbing, from close to USD 227.50/KG in Q4 2025 up to about USD 238.50/KG in Q1 2026, then near USD 246.50/KG in Q2, a gain of just above 3.4%. Pharmaceutical-sector demand and logistical bottlenecks drove both quarters.
The global rise in urinary tract infection cases, driven by lifestyle changes and increasing traditional antibiotic resistance, has boosted demand for newer and effective antibiotics like nitroxoline. A growing aging population, more likely to be affected by these infections, has added further demand.
The global average is likely to run in the USD 238 to 268/KG range, with steady demand growth and logistical bottlenecks continuing to support gains through the back half of the year.
The United States carries by far the highest cost among tracked markets. Germany sits well below that on manufacturing bottlenecks, and France and the United Kingdom price lowest, both affected by their own regulatory and labor supply challenges.
The figures here are updated monthly. Real-time pricing is available directly from the team.
Global production challenges and logistical bottlenecks affecting raw material shipments sit at the core. Regulatory adjustments affecting essential medicine pricing, and demand growth tied to antibiotic resistance and population aging, add further influence.
India and China dominate global exports of this API, with Germany, Algeria, and France representing major importing markets that rely on this international supply chain for their pharmaceutical formulation needs.
Raw material shipment and logistics reports from major exporting regions are usually the earliest signal worth tracking, since delays there tend to ripple through production timelines and pricing. Watching urinary tract infection prevalence and antibiotic resistance trends also helps anticipate longer-term demand growth.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.